Oct. 13, 2026

MATTER SERIES: AI in Commercial Pharma

EVERSANA INTOUCH is proud to support MATTER’s AI in Commercial Pharma series, bringing together pharmaceutical executives, entrepreneurs and investors to explore how AI is transforming commercial organizations. Through a series of expert-led discussions, attendees will gain practical perspectives on emerging opportunities, adoption challenges and the future of AI across commercial pharma.

FEATURED EVENT

Where AI is (and isn’t) Changing Commercial Work

Oct 13 | 3-5PM CT

Chicago, IL

AI is creating new opportunities across commercial pharma, but organizations continue to evaluate where it is delivering meaningful value and how best to scale adoption. This session will bring together commercial, market access, analytics and innovation leaders to discuss their approaches to AI, including how they assess solutions, what they are building versus buying, and the barriers impacting adoption.

Featured Speakers

Faruk Capan
  • Faruk Capan, Founder, EVERSANA INTOUCH and Chief Innovation Officer, EVERSANA
  • Jared Joselyn, Senior Vice President, Global Head of Digital Health and Emerging Disruptive Growth Exploration, Sanofi
  • Tom Gibbs, Executive Vice President, Lundbeck US

Contact Us

Attending MATTER: AI in Commercial Pharma?

Schedule a meeting with our experts.